thyroid cancer

Vivian Weiss, MD, PhD, center, George Xu, left, and Matthew Loberg led a multidisciplinary study that identified a molecular signature for aggressive thyroid cancer, which could help guide treatment approaches for patients. (photo by Susan Urmy)

Researchers discover molecular signature for aggressive thyroid cancer

A Vanderbilt study found that a molecular signature that predicts aggressive thyroid cancer could help guide treatment approaches for patients.

Pediatric surgeon’s medical career began with a lucky catch

While he was in medical school, pediatric surgeon Joseph Fusco, MD, learned in an unusual way that he had thyroid cancer.

Yike Li, PhD, and Maria Powell, PhD, examine patient Judit Kiss during a follow-up appointment at the Vanderbilt Voice Center.

Implanted stimulator used to treat vocal cord paralysis

Vanderbilt is the only place in the world that has an implantable bilateral pacemaker that can stimulate opening of both vocal folds in patients with bilateral vocal fold paralysis, allowing them to both breathe and speak.

Thyroid cancer paper lands national recognition

Obese children, young adults at higher risk for thyroid cancer

Children and young adults who are obese are at greater risk for malignant thyroid nodules, according to new study from Monroe Carell Jr. Children’s Hospital at Vanderbilt.

Grant bolsters Weiss’ pediatric thyroid cancer research

Vivian Weiss, MD, PhD, has been named a 2020 V Scholar and will receive $200,000 from the V Foundation for Cancer Research.